The present invention provides a unique combination of herbal ingredients designed to improve human sexual performance and for the treatment of disorders of Male Sexual Dysfunction. The composition is comprised of Sulfur, Cnidium, Petrolatum Jelly, Cumin, Cassia, Schisandra, Eucommiacease, Borneal, Zingiber officinale in amounts effective to produce desired results.

A herbal composition for treatment of digestive system related diseases comprising,

TABLE-US-00001 1) Foeniculum vulgare 50.47% to 85.43% 2) Trachyspemum ammi 29.93% to 9.75% 3) Dolichandrone falcata 0.20% to 0.02% 4) Morinda citrifolia 0.20% to 0.05% 5) Syzygium aromatic 3.90% to 0.75% 6) Piper nigrum 3.90% to 0.50% 7) Cinnamomum zeylanicum 3.90% to 1.00% 8) Black salt 2.10% to 1.00% 9) Sodium bicarbonate 1.50% to 0.50% 10) IIIilcium verum 3.90% to 1.00%

A herbal composition for treatment of digestive system related diseases comprising,

TABLE-US-00001 1) Foeniculum vulgare 50.47% to 85.43% 2) Trachyspemum ammi 29.93% to 9.75% 3) Dolichandrone falcata 0.20% to 0.02% 4) Morinda citrifolia 0.20% to 0.05% 5) Syzygium aromatic 3.90% to 0.75% 6) Piper nigrum 3.90% to 0.50% 7) Cinnamomum zeylanicum 3.90% to 1.00% 8) Black salt 2.10% to 1.00% 9) Sodium bicarbonate 1.50% to 0.50% 10) IIIilcium verum 3.90% to 1.00%

Disclosed are compositions and methods for their use for cosmetic applications. The composition can include Schisandra chinensis fruit extract, Secale cereale (rye) seed extract, Centella asiatica meristem cell culture, Alpinia galangal leaf extract, dihydroxymethyl chromone, tripeptide-1, tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate, Alteromonas ferment filtrate, Pisum sativum (pea) extract, or combinations thereof. An effective amount of the composition can be applied on skin to inhibit production of TNF- production, tyrosinase, and/or elastase in skin, inhibit the Matrix Metalloproteinase Enzyme activity in skin, and/or promote the production of fibronectin, collagen, elastin, laminin, and/or hyaluronic acid in skin.

Disclosed are compositions and methods for their use for cosmetic applications. The composition can include Schisandra chinensis fruit extract, Secale cereale (rye) seed extract, Centella asiatica meristem cell culture, Alpinia galangal leaf extract, dihydroxymethyl chromone, tripeptide-1, tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate, Alteromonas ferment filtrate, Pisum sativum (pea) extract, or combinations thereof. An effective amount of the composition can be applied on skin to inhibit production of TNF- production, tyrosinase, and/or elastase in skin, inhibit the Matrix Metalloproteinase Enzyme activity in skin, and/or promote the production of fibronectin, collagen, elastin, laminin, and/or hyaluronic acid in skin.

This disclosure is directed to compositions comprising the Schisandra Sphenanthera extract and a plant-based compound that comprises one or more of triptolide, colchicine, wilforlide A, celastrol, and their analogs or derivatives. Further disclosed herein are methods of increasing the bioavailability of these plant-based compounds and methods of treating diseases with the compositions.

This disclosure is directed to compositions comprising the Schisandra Sphenanthera extract and a plant-based compound that comprises one or more of triptolide, colchicine, wilforlide A, celastrol, and their analogs or derivatives. Further disclosed herein are methods of increasing the bioavailability of these plant-based compounds and methods of treating diseases with the compositions.

The present invention is directed to therapeutic methods and compositions for treating non-small cell lung cancer in a subject comprising administering an effective amount of an extract or powder of a herbal mixture, optionally with an anti-cancer agent to said subject. The herbal mixture comprises a component of at least one species from each of the genus Astragalus, Cimicifuga Foetida rhizoma, Ophiopogon radix, Atractylodes lancea rhizoma, Panax ginseng-Red, Atractylodes rhizoma-White, Massa medicata fermentata, Citrus reticulata-Viride, Citrus reticulata, Glycyrrhiza radix, Schisandra fructus, Angelica sinensis radix, Phellodendron cortex, Alisma rhizoma, Pueraria radix, Ziziphus fructus-Red, and Zingiber officinale radix.

The present invention is directed to therapeutic methods and compositions for treating non-small cell lung cancer in a subject comprising administering an effective amount of an extract or powder of a herbal mixture, optionally with an anti-cancer agent to said subject. The herbal mixture comprises a component of at least one species from each of the genus Astragalus, Cimicifuga Foetida rhizoma, Ophiopogon radix, Atractylodes lancea rhizoma, Panax ginseng-Red, Atractylodes rhizoma-White, Massa medicata fermentata, Citrus reticulata-Viride, Citrus reticulata, Glycyrrhiza radix, Schisandra fructus, Angelica sinensis radix, Phellodendron cortex, Alisma rhizoma, Pueraria radix, Ziziphus fructus-Red, and Zingiber officinale radix.

The present invention provides a cellulose derivative free capsule that may be organic and plant-based. The capsule includes organic pullulan, one or more herbal extracts in a powder form or as an aqueous alcoholic extract, and a mixture of plant-based oil and plant-based lecithin. The mixture of oil and lecithin may have a viscosity of 250 to 1000 cP at 25? C., and with the herbal extract may have a viscosity of 1000 to 2500 cP at 25? C.